Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Injectable Gels Toughen up after Entering the Body

Published: Friday, November 16, 2012
Last Updated: Friday, November 16, 2012
Bookmark and Share
These more durable gels could find applications in drug delivery and tissue engineering.

Gels that can be injected into the body, carrying drugs or cells that regenerate damaged tissue, hold promise for treating many types of disease, including cancer. However, these injectable gels don’t always maintain their solid structure once inside the body.

MIT chemical engineers have now designed an injectable gel that responds to the body’s high temperature by forming a reinforcing network that makes the gel much more durable, allowing it to function over a longer period of time.

The research team, led by Bradley Olsen, an assistant professor of chemical engineering, described the new gels in a recent issue of the journal Advanced Functional Materials. Lead author of the paper is Matthew Glassman, a graduate student in Olsen’s lab. Jacqueline Chan, a former visiting student at MIT, is also an author.

Olsen and his students worked with a family of gels known as shear thinning hydrogels, which have a unique ability to switch between solid-like and liquid-like states. When exposed to mechanical stress — such as being pushed through an injection needle — these gels flow like fluid. But once inside the body, the gels return to their normal solid-like state.

However, a drawback of these materials is that after they are injected into the body, they are still vulnerable to mechanical stresses. If such stresses make them undergo the transition to a liquid-like state again, they can fall apart.

“Shear thinning is inherently not durable,” Olsen says. “How do you undergo a transition from not durable, which is required to be injected, to very durable, which is required for a long, useful implant life?”

The MIT team answered that question by creating a reinforcing network within their gels that is activated only when the gel is heated to body temperature (37 degrees Celsius).

Shear thinning gels can be made with many different materials (including polymers such as polyethylene glycol, or PEG), but Olsen’s lab is focusing on protein hydrogels, which are appealing because they can be designed relatively easily to promote biological functions such as cellular adhesion and cell migration.

The protein hydrogels in this study consist of loosely packed proteins held together by links between protein segments known as coiled coils, which form when two or three helical proteins coil into a ropelike structure.

The MIT researchers designed their hydrogel to include a second reinforcing network, which takes shape when polymers attached to the ends of each protein bind together. At lower temperatures, these polymers are soluble in water, so they float freely in the gel. However, when heated to body temperature, they become insoluble and separate out of the watery solution. This allows them to join together and form a sturdy grid within the gel, making it much more durable.

The researchers found that gels with this reinforcing network were much slower to degrade when exposed to mechanical stress and were significantly stiffer. This offers a promising way to thwart the tendency of shear thinning materials to erode once in the body, says Jason Burdick, an associate professor of bioengineering at the University of Pennsylvania.

“Building in this secondary network based on a different type of mechanism is a very elegant way to overcome that obstacle through material design,” says Burdick, who was not part of the research team.

Another advantage of these gels is that they can be tuned to degrade over time, which would be useful for long-term drug release. The researchers are now working on ways to control this feature, as well as incorporating different types of biological functions into the gels.

The research was funded by the U.S. Army Research Office through MIT's Institute for Soldier Nanotechnologies (ISN). Potential applications of these nanostructured gels to soldier medicine include preventing blood loss, accelerating wound healing and protecting against infections and disease.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Curing Disease by Repairing Faulty Genes
New delivery method boosts efficiency of CRISPR genome-editing system.
Wednesday, February 03, 2016
No More Insulin Injections?
Encapsulated pancreatic cells offer possible new diabetes treatment.
Tuesday, January 26, 2016
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Monday, January 25, 2016
Supply Chain
Chemists discover how a single enzyme maintains a cell’s pool of DNA building blocks.
Wednesday, January 13, 2016
How Cancer Cells Spread
Study offers new targets for drugs that may prevent cancer from spreading.
Thursday, December 17, 2015
Delivering microRNAs for Cancer Treatment
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.
Wednesday, December 09, 2015
Using Ultrasound to Improve Drug Delivery
New approach could aid in treatment of inflammatory bowel disease.
Friday, October 23, 2015
Drug-Resistance Mechanism in Tumor Cells Unravelled
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Friday, October 23, 2015
Biologists Find Unexpected Role for Amyloid-Forming Protein
Yeast protein could offer clues to how Alzheimer’s plaques form in the brain.
Monday, September 28, 2015
Viruses Join Fight Against Harmful Bacteria
Engineered viruses could combat human disease and improve food safety.
Friday, September 25, 2015
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Tuesday, September 22, 2015
A Metabolic Master Switch Underlying Human Obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Friday, August 21, 2015
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Friday, July 31, 2015
Firms “Under-invest” in Long-Term Cancer Research
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Thursday, July 30, 2015
Nanoparticles Can Clean Up Environmental Pollutants
Researchers have found that nanomaterials and UV light can “trap” chemicals for easy removal from soil and water.
Thursday, July 23, 2015
Scientific News
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Enzyme Links Age-Related Inflammation, Cancer
Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration.
Viral Gene Editing System Corrects Genetic Liver Disease
Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Curing Disease by Repairing Faulty Genes
New delivery method boosts efficiency of CRISPR genome-editing system.
'Junk' DNA Plays Role in Preventing Breast Cancer
Supposed "junk" DNA, found in between genes, plays a role in suppressing cancer, according to new research by Universities of Bath and Cambridge.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!